Uses of Norten 10mg Tablet
Norten 10mg Tablet is used for the treatment or prevention of the following disease(s):
Hypertension, Angina, Blood Pressure, Irregular Heartbeats
Side effects of Norten 10mg Tablet
Precautions while taking Norten 10mg Tablet
Dosage of Norten 10mg Tablet
Overdose of Norten 10mg Tablet
Onset of Action of Norten 10mg Tablet
Duration of Action of Norten 10mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Norten 10mg Tablet
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
ACE inhibitors: Increased risk of hypotension, especially in presence of acute MI.
allergen immunotherapy, allergenic extracts for skin testing: Increased risk of serious systemic adverse reactions or anaphylaxis.
amiodarone: Additive depressant effects on.
conduction, negative inotropic effects anesthetics hydrocarbon inhalation:Increased risk of myocardial depression and hypotension
beta blockers: Additive beta blockade effects.
bupivacaine, lidocaine, mepivacaine: Decreased clearance of these drugs, possibly increased risk of toxicity
calcium channel blockers, clonidine, diazoxide, guanabenz, resperpine, other hypotension-producing drugs: Additive hypotensive effect and, possibly, other beta blockade effects.
catecholamine-depleting drugs, such as reserpine: Increased risk of hypotension, bradycardia, vertigo, syncope, and orthostatic hypotension.
cimetidine: Possibly interference with propranolol clearance.
digitalis glycosides: Increased risk of bradycardia.
diltiazem: Increased risk of bradycardia, hypotension, high-degree heart block, and heart failure.
dobutamine, isoproterenol: Reversed effects of propranolol.
doxazosin, terazosin: Increased risk of orthostatic hypotension.
epinephrine: Increased risk of uncontrolled hypertension.
estrogens: Decreased antihypertensive effect of propranolol.
fentanyl, fentanyl derivatives: Possibly increased risk of initial bradycardia after induction doses of fentanyl or a derivative with long-term propranolol use.
glucagon: Possibly blunted hyperglycemic response.
insulin, oral antidiabetic drugs: Possibly impaired glucose control, masking of tachycardia in response to hypoglycemia.
MAO inhibitors, tricyclic antidepressants: Increased risk of significant hypertension.
neuroleptic drugs: Increased risk of hypotension and cardiac arrest.
neuromuscular blockers: Possibly potentiated and prolonged action of these drugs.
NSAIDs: Possibly decreased hypotensive effects.
phenothiazines: Increased blood levels of both drugs.
phenytoin: Additive cardiac depressant effects with parenteral phenytoin.
prazosin: Increased risk of first-dose hypotension.
propafenone: Increased blood level and half life of propranolol.
quinidine: Increased propranolol level, resulting in higher degrees of beta blockade and orthostatic hypotension.
sympathomimetics, xanthines: Possibly mutual inhibition of therapeutic effects.
thyroxine: Possibly decreased T3 level.
verapamil: Increased risk of bradycardia, heart failure, and cardiovascular collapse.
warfarin: Increased risk of bleeding.
Activity :-
alcohol: Possibly increased plasma propranolol level.
nicotine chewing gum, smoking cessation, smoking deterrents: Increased therapeutic effects of propranolol.